We have characterized comprehensive transcript and proteomic profiles of cell lines corresponding to normal breast (MCF10A), noninvasive breast cancer (MCF7) and invasive breast cancer (MDA-MB-231). The transcript profiles were first analysed by a modified protocol for representational difference analysis (RDA) of cDNAs between MCF7 and MDA-MB-231 cells. The majority of genes identified by RDA showed nearly complete concordance with microarray results, and also led to the identification of some differentially expressed genes such as lysyl oxidase, copper transporter ATP7A, EphB6, RUNX2 and a variant of RUNX2. The altered transcripts identified by microarray analysis were involved in cell-cell or cell-matrix interaction, Rho signaling, calcium homeostasis and copper-binding/sensitive activities. A set of nine genes that included GPCR11, cadherin 11, annexin A1, vimentin, lactate dehydrogenase B (upregulated in MDA-MB-231) and GREB1, S100A8, amyloid b precursor protein, claudin 3 and cadherin 1 (downregulated in MDA-MB-231) were sufficient to distinguish MDA-MB-231 from MCF7 cells. The downregulation of a set of transcripts for proteins involved in cell-cell interaction indicated these transcripts as potential markers for invasiveness that can be detected by methylation-specific PCR. The proteomic profiles indicated altered abundance of fewer proteins as compared to transcript profiles. Antisense knockdown of selected transcripts led to inhibition of cell proliferation that was accompanied by altered proteomic profiles. The proteomic profiles of antisense transfectants suggest the involvement of peptidyl-prolyl isomerase, Raf kinase inhibitor and 80 kDa protein kinase C substrate in mediating the inhibition of cell proliferation.
Introduction
The transformation of a normal cell into a cancer cell has been correlated to altered expression of a variety of genes Becker et al., 2005) . The expression of some of these genes is a direct result of sequence mutation, whereas other changes occur due to alterations in gene products that participate in specific pathways. The changes in gene expression have been routinely characterized by classical subtraction hybridization and differential display approaches (Cerosaletti et al., 1995; Alpan et al., 1996) . With the availability of the human genome sequence and sequences for a number of other model organisms, traditional methods have largely been replaced by gene microarrays (Khan et al., 2001) . These analyses have been used to characterize the molecular basis of a variety of diseases including cancer. A comprehensive analysis of a large number of cancer cell lines allowed clustering of genes into groups based on their expression patterns in phenotypically related cell lines (Khan et al., 2001; Dan et al., 2002; Rosenwald et al., 2002; van't Veer et al., 2002) . The results of profiling experiments indicated expression of specific gene clusters in cell lines that have the same origin or have arisen from the same organ (Ross et al., 2000) . A complementary approach that has been used in limited ways is proteomics. Proteomics scores for changes in different proteins and peptides in cells with characteristic phenotypic differences. However, a comparative analysis of transcripts and proteins to establish a relationship between transcript changes and protein levels has not yet become routine.
Although expression profiling of tumor tissue and its comparison with normal tissue, in principle, is most appropriate to obtain the genetic signatures of a tumor type, such comparisons have not been free of attendant complications. These complications arise due to heterogeneity of tumor specimens wherein any cell typespecific changes are likely to be masked by other cell types that constitute the tumor specimen. For this reason, well-characterized cell lines established from tumor tissue may prove more informative and have been considered useful by cancer researchers. Comparing gene profiles between cell lines has the potential to reveal genes that could be causative for the phenotype and other genes that can serve as tumor biomarkers.
Our investigations are aimed at designating a subset of transcripts that could distinguish a normal breast cell from a breast cancer cell and help to predict tumorigenic or metastatic potential of a transformed cell. We describe here transcript and proteomic profiles of a normal breast cell line, a tumorigenic but noninvasive breast carcinoma cell line and an invasive breast carcinoma cell line, and summarize them as a set of candidate biomarkers or targets for therapeutic intervention. The comparison of transcript profiles with proteomic profiles demonstrated that altered proteins were not always represented in the microarray designated profiles and vice versa. Furthermore, we have targeted five transcripts that were upregulated in MCF7 cells for investigating their role in cell proliferation pathways. The proteomic profiles have revealed that inhibition of cell proliferation by antisense knockdown was mediated by a specific set of proteins.
Results

Representational difference analysis
As described in the Materials and methods section, RDA was performed by using cDNAs from MCF7 and MDA-MB-231 as tester/driver or driver/tester combination. The difference product in the first case represents the genes that are either upregulated in or specific to MCF7. On the other hand, the difference product of MDA-MB-231 (tester) and MCF7 (driver) hybridization resulted in the isolation of cDNAs that are either upregulated in or specific to MDA-MB-231. The initial linkers used in this protocol had internal BglII sites. One strand of the linker was used to amplify both the tester and driver cDNAs after linkers had been ligated to cDNAs. After removal of linkers from amplified cDNAs by digestion with BglII, a dephosphorylated BglII adaptor was ligated to tester DNA. The BglII adaptor had an internal EcoRI site. The difference product was digested with EcoRI and cloned in pBlueScript vector. The cloning efficiency of the difference product was very low (5 Â 10 4 c.f.u./mg of DNA). The low efficiency of cloning is attributed to a substantial fraction of amplified DNA product that is refractory to restriction digestion. The sequencing of a set of 100 clones each from the difference libraries revealed 50 different kinds of clones. The majority of these sequences were short fragments and represented either 3 0 regions or internal fragments of transcripts. A summary of these clones is presented in Table 1 . The involvement of the majority of these cDNAs is well characterized either in tumorigenesis or in metastasis. The phenotypic characteristics of MCF-7 and MDA-MB-231 ideally match with the biological significance of these genes. The alterations in transcripts for Rho signaling proteins, Ca 2 þ binding/requiring proteins, tight junctions/anchoring junctions/gap junctions, copper binding or sensitive proteins, and RUNX2 are particularly noteworthy.
The differential expression of a representative number of RDA clones was validated by semiquantitative PCR. As shown in Figure 1 , these transcripts were either specific to or upregulated in the cell line that was used as a tester. Such analyses demonstrated that more than 90% of the clones were differentially expressed. The abundance of transcripts and the results of RT-PCR were also confirmed by Northern blotting (Figure 2 ). The pattern of hybridization clearly indicates that all these transcripts showed differential expression in MCF7 and MDA-MB-231 cells that were used as driver/tester combinations for the RDA.
Gene microarrays
After obtaining preliminary molecular signatures of MCF7 and MDA-MB-231 cells by RDA, we used Affymetrix gene micoarrays to expand the above analysis to identify a comprehensive set of transcripts that is deregulated in invasive breast carcinoma cells. The comparisons of cell lines on the basis of transcripts that are either present or absent as shown in Figure 3 revealed that a set of 123 genes distinguishes MDA-MB-231 cells from MCF7 and MCF10A. These genes can be classified by their involvement in functional classes such as transcription, signal transduction, cell adhesion, cell cycle, metabolism, transport, response genes and development (Figure 4 ). The majority of these genes participated in the process of signal transduction followed by transcription, cell adhesion and metabolism, respectively. A few transcripts in these classes were tested by real-time RT-PCR to confirm their altered abundance. The selected transcripts showed changes ranging between two-and 10-fold, 11-and 20-fold and greater than 20-fold, and were in close agreement with the results of microarray analysis. The qualitative pattern of change observed in microarrays analysis was readily reproduced by real-time or semiquantitative RT-PCR for all transcripts tested.
The number of altered transcripts was over 1000 based on a change of twofold or greater, and a majority of these genes show changes varying between two-and fourfold ( Figure 5 ). Interestingly, with all comparisons combined, there were 21 genes downregulated more than 50-fold and 55 genes that were upregulated more than 18-fold when specific cell line pairs were compared ( Figure 5 ). The transcripts that represent the extremes of upregulated and downregulated scale can allow distinction between MCF7 and MDA-MB-231 cells. These transcripts include GPCR11, cadherin 11, annexin A1, vimentin, lactate dehydrogenase B (upregulated in MDA-MB-231) and GREB1, S100A8, amyloid b precursor protein, claudin 3 and cadherin 1 (downregulated in MDA-MB-231). The distinction between MCF7 and MCF10A may be made based on keratin 19, serine protease, amyloid b precursor, neuropeptide Y receptor Y1 (upregulated in MCF7) and caldesmon, annexin A1, epithelial membrane protein 1, S100A2, keratin 15 (downregulated in MCF7). Likewise, MDA-MB-231 cells differ from MCF10A in vimentin, epithelial membrane protein 3, cadherin 11, GPCR 116, collagen type XIII a 1, Bcl2-associated athanogene 2 (upregulated in MDA-MB-231) and keratin 15, cystatin A, cadherin 1, CD24, calcium-activated chlor- (Table 3) . While Ca 2 þ homeostasis is extensively investigated in human cancers, copper homeostasis is an underexplored area. The alterations in copper homeostasis in breast carcinoma cells were reflected by changes in transcripts corresponding to a variety of copper-binding or copper-sensitive proteins/enzymes (Tables 1 and 4 ). The deregulation of Rho signaling was evident from changes in various proteins involved in this pathway (Table 4) . 
Present/Absent Calls
Proteome analysis
To identify altered abundance of proteins and relate it to transcript profiles, we characterized the protein profiles of MCF-10A, MCF-7 and MDA-MB-231 cells. Typically, >300 protein spots could be visualized in silverstained gels, and there were far fewer protein spots in gels that were stained with Coomassie blue. The comparison of MCF7 or MDA-MB-231 proteins with MCF-10A revealed that MCF-7 had 11 unique protein spots, while MDA-MB-231 had 15 spots that were not seen in MCF-10A. These proteins were either specific to or upregulated in these cell lines. The identity of these proteins is shown in Table 5 . Out of these 26 protein spots, only 25 yielded amino-acid sequence. As shown in the table, the list includes proteins involved in stress response, protein-tagging activities, calcium-binding and calcium homeostasis proteins and some regulatory proteins. Prominent among these changes were proteins involved in calcium homeostasis such as crocalbin, calreticulin, calcyclin and reticulocalbin. The changes in signaling pathways between the two cell lines were indicated by altered levels of Rho GDP dissociation inhibitor 1, an apoptosis/differentiation regulating protein galectin, Myc expression regulator far upstream binding protein-1 and the microtubule regulator protein stathmin. The translation initiation factors 5A and 4H were also selectively upregulated in MDA-MB-231 cells. Changes in proliferation characteristics and protein profiles in response to transfection with antisense constructs of selected transcripts We had observed significant upregulation of transcripts for DNA replication complex protein GINS PSF2, trefoil factor 3, aurora kinase AIK2, protein kinase H11 and secreted protein XAG in MCF7 cells. We reasoned that antisense knockdown of the above genes in MCF7 cells might indicate pathways involved in tumorigenesis and invasiveness. MCF7 cells were transfected with empty vector pCDNA3.1 or antisense constructs of the above genes. A semiquantitative amplification of pCDNA marker gene by RT-PCR confirmed the presence of the transfected construct in a significant proportion of the cell population. The transfected cells also showed a decrease in the target transcripts as observed by RT-PCR. The effects of antisense transfections were scored by growth characteristics of the transfectants. The cell proliferation was reduced between 15 and 40% when antisense transfectants were compared to cells transfected with empty vector.
In order to relate decreased proliferation of transfectants to altered proteins, proteomic profiles of transfectants were compared with vector controls. The comparison of protein profiles of cells transfected with empty vector or antisense construct revealed alterations in several proteins for each transfectant (Table 6 ). These proteins included stress-response proteins, calciumregulating proteins, translation factors, ubiquitin, proteins of electron transport chain and oxidative phosphorylation, signaling proteins, cytokeratins, actin and actin regulating proteins and general regulatory factors. The number of altered proteins varied between 5 and 15 for various transfections. Peptidyl prolyl cis-trans isomerase, calcium-regulating proteins, SOD, galectin, histidine triad protein and PKC substrate were prominent among altered proteins. We performed database searches to identify interactors for all proteins that were altered in transfected cells and identified nearly 350 proteins (data not shown). A significant number of these interacting proteins are involved in transcriptional regulation. 
Discussion
The results presented here validate the gene profiles obtained from different expression platforms ranging from subtractive hybridization to gene microarrays and proteomic analysis. The RDA protocol is powerful enough to yield important genes that show significant alterations in their expression between cell lines, and can lead to isolation of full-length cDNAs by using appropriate modifications (Baskaran et al., 1996; Jacob et al., 1997) . The detection of RUNX2, variant of RUNX2, EphB6, prion protein, lysyl oxidase and a copper transporter ATP7A transcripts by RDA warrant specific mention. RUNX transcription factors bind specific motifs on target gene promoters and regulate gene expression leading to cell growth, proliferation and differentiation (Pratap et al., 2003) . RUNX2 and its variant have differential repression activity toward the promoter of the cyclin-dependent kinase inhibitor (p21CIP1) (Westendorf et al., 2002) . The loss of EphB6 expression due to methylation of its promoter is related to invasiveness of MDA-MB-231 (Fox and Kandpal, 2004; unpublished observations) . Lysyl oxidase, a copper-sensitive enzyme, causes oxidative deamination of lysine and hydroxy lysines of collagen to aldehyde forms to stabilize collagen fibrils (Siegel, 1976) that are found in invasive breast carcinoma cells (Akiri et al., 2003) . The activation of LOX is dependent on copper that is internalized and then transported to trans golgi network by copper transporter ATP7A (Pase et al., 2004) , a protein mutated in Menkes disease (Moller et al., 2005) . Prion protein has also been reported as a (Johnson, 1991; Kousidou et al., 2004; Shao et al., 2005) and promoter methylation (Costa et al., 2004) . As several transcripts coding for junctional proteins are downregulated in invasive cells, we postulate that methylation-specific PCR can be exploited to use these transcripts as biomarkers of tumor cells in general and invasiveness in particular. The changes in cell-cell interaction correlate to cell phenotypes because such interactions influence Rho/Ras signal transduction pathways and vice versa (Malliri and Collard, 2003; Nagaraja and Kandpal, 2004; Ridley, 2004) , and lend credence to the significance of altered transcripts for Rho and Rho GEFs as presented here.
Early changes in calcium homeostasis as measured by calcium excretion have been reported in breast cancer (Campbell et al., 1983) , and altered calcium signaling has been shown in invasive lung carcinoma cells (Amuthan et al., 2002) . Prominent among calcium-binding proteins are S-100 protein, a group of intracellular messengers that respond to transient changes in calcium concentration by binding to specific receptors (Marenholz et al., 2004) and regulate cell growth, differentiation and motility, transcription and cell cycle. The S-100 proteins detected in the present study map to chromosome 1q21, a region of genome that is frequently altered in human breast cancer cells (Bieche et al., 1995) . Calcium ions act as a second messenger in specific signaling pathways in a variety of cancers (Missiaen et al., 2000) and are known to alter calcineurin to activate transcription factors such as NFATc (Luo et al., 1996) .
As dictated by post-transcriptional regulation, protein profiles showed far fewer changes as compared to transcript profiles, and the knockdown of five selected genes in MCF7 cells produced interesting changes in protein profiles. These genes, namely, XAG (secretory Xenopus laevis protein), trefoil factors 3, human aurora2 kinase AIK2, protein kinase H11 and DNA replication complex GINS PSF2, have been shown to be estrogen responsive, oncogenic or involved in tumorigenesis (Yu et al., 2001; Fletcher et al., 2003; Katoh, 2003; Warner et al., 2003; Takayama et al., 2003) . The antisense constructs of these genes appeared to work as siRNAs as suggested by the reduction in the transcript detected in RT-PCR of RNA isolated from the transfected cells. The involvement of the above transcripts in invasive potential is apparent from the observed upregulation of calcium-binding proteins in transfected MCF7 cells, which is comparable to their levels in MDA-MB-231 cells. The proteins that appear to mediate inhibition of proliferation in antisense-transfected cells include PKC substrate, Raf kinase inhibitor, histidine triad nucleotide-binding protein and peptidy-prolyl isomerase (Pin1). We believe histidine triad protein effects are most likely mediated via its interaction with ATM protein. Raf kinase inhibitor (Keller et al., 2004) and ATM (Hall, 2005) have been conclusively linked to transformation of cells, and the activity of Pin1 has been related to p53-mediated signaling pathways (Mantovani et al., 2004; Berger et al., 2005) . In this context, p53 activation has also been hypothesized by Cu-SOD prion-like enzyme (Wiseman, 2005) . Thus, alterations in copper homeostasis and p53-mediated signaling may be considered as a significant regulatory mechanism in tumorigenesis.
In summary, we have presented here a set of candidate genes that can serve as biomarkers for tumorigenesis and invasiveness, and some of these markers may be used to develop DNA-based diagnostic tests. The alterations in transcripts for copper homeostasis genes suggest copper chelation or inhibition of copper transporter ATP7A as potential targets for therapeutic application. The modulation of RUNX2 splicing variants by chemicals that affect splicing machinery may also be explored as a therapeutic modality. The changes in EphB6 expression, if confirmed in tumor specimens, may have prognostic significance.
Materials and methods
Breast cancer cell lines
We used MCF-10A, a cell line established from normal breast, and two breast carcinoma cell lines MCF-7 and MDA-MB-231 that vary in their in vitro and in vivo invasiveness. All cells were cultured at 371C/7% CO 2 . MCF-10A cells were grown in 1:1 DMEM:F12 media (Gibco) with 5% horse serum (Gibco), 20 mM HEPES, 10 ng/ml EGF (Invitrogen), 10 ml/l PenStrepGlutamine (10 000 U/ml penicillin, 10 000 mg/ml streptomycin and 29.2 mg/ml L-glutamine), 10 mg/ml insulin (Invitrogen), 0.1 mg/ml Cholera Toxin (Sigma) and 500 ng/ml hydrocortisone (Sigma). MCF-7 and MDA-MB-231 cells were grown in DMEM (Gibco) supplemented with 2 mM L-glutamine (Gibco), 1 mM sodium pyruvate (Gibco), 5 ml/l penstrep (5000 U/ ml penicillin and 5000 mg/ml streptomycin), and 10% fetal bovine serum (Hyclone).
Total RNA isolation RNA was isolated from 85 to 95% confluent 10 cm tissue culture dishes using TRI reagent (Molecular Research Center Inc.) with slight modifications to the recommended protocol. Approximately 10 million cells were mixed with 1.0 ml Tri Reagent, the mixture was extracted with chloroform and the aqueous phase containing RNA was separated. The RNA was precipitated with isopropanol, the pellet washed sequentially with 80 and 100% ethanol, then dried and resuspended in DEPC-treated water. RNA was stored in aliquots at À701C. The quality of RNA was visualized by running on a formaldehyde gel. The appearance of ribosomal RNA bands indicated that RNA was not degraded during the procedure. The amount of RNA was determined by its absorbance at 260 nm.
DNAase treatment of total RNA
To remove DNA contamination, 20 mg of RNA (quantified spectrophotometrically) was treated with 500 ng DNAase I, 80 U RNasin (Promega) and 1 mM MgCl 2 in Tris buffer in a total volume of 50 ml. The reaction was carried out at 371C for 1 h and the DNAase inactivated by heating to 651C for 30 min.
Representational difference analysis (RDA) RDA of cDNAs is a modification of genomic RDA (Lisitsyn et al., 1993) . We performed RDA in the following two ways. In one experiment, MCF-7 cDNA was used as a driver and MDA-MB-231 cDNA as a tester. In the second experiment, MCF-7 cDNA was used as a tester and MDA-MB-231 cDNA as a driver. The protocol has been describer previously (Jacob et al., 1997) . Briefly, first-strand synthesis was carried out using a commercial cDNA synthesis kit as per the manufacturer's protocol. A linker with a BglII site was ligated to the tester as well as the driver cDNA. A primer specific to one of the linker strands was used to PCR amplify the linker-ligated cDNAs. The linkers were then removed by digesting the cDNA with BglII and the digested cDNA was gel purified. A second set of unphosphorylated BglII adaptors was ligated to the tester cDNA only. The tester and driver DNAs were hybridized in a 5 ml reaction volume at a ratio of 1:40. After hybridization, the ends of the tester homoduplexes were repaired with Klenow polymerase and 1 ml of the reaction mixture was diluted to 100 ml. The difference product was obtained by amplifying 1 ml of the diluted mixture using the top strand of the ligated adaptor as a primer. The amplified difference product was digested with EcoRI and cloned in a pBlueScript vector. Individual clones were picked up and sequenced by Sanger's dideoxy chain termination method. Representative clones were validated by Northern analysis and semiquantitaive RT-PCR.
Microarray analysis
The GeneChips, Human Genome U133A 2.0, (Affymetrix, Santa Clara, CA, USA) used in this study contained approximately 22 000 probe sets corresponding to 18 400 transcripts and variants, including 14 500 well-characterized human genes.
Total RNA was converted into double-stranded cDNA by using SuperScript II (Invitrogen, Carlsbad, CA, USA) and an oligo-dT primer containing a heel of the T7 RNA polymerase promoter sequence. The reaction mixture containing doublestranded cDNA was extracted with phenol-chloroform, precipitated with ethanol, and dissolved in 12 ml RNase-free water. The cDNA was transcribed in vitro by using a RNA transcription labeling kit (Enzo Biochem, Famingdale, NY, USA) with 6 ml of double-stranded cDNA in the presence of ATP, CTP, GTP, UTP, bio-11-CTP and bio-16-UTP. The biotinylated RNA was purified by using an affinity column (Qiagen, Valencia, CA, USA) and fragmented randomly, by heating to 951C in the presence of fragmentation buffer, between sizes of 35 and 200 bases. The GeneChips were hybridized overnight at 451C in hybridization oven in a solution containing fragmented cRNA, control oligonucleotide B2, 20 Â eucaryotic hybridization controls, herring sperm DNA, acetylated BSA and 2 Â hybridization buffer. The GeneChips were washed and stained with streptavidinphycoerythrin and the antibody in 2 Â MES stain buffer, acetylated BSA, and optically read at a resolution of 6 mm with a Affymetrix GeneChip scanner 3000. Affymetrix MICRO-ARRAY SUITE was used for initial data preparation (generation of .CHP files). Normalization (quantile method) and calculation of signal intensities was performed with the software package RMA from the R project (http://www.rproject.org/). For every cell line, three replicates were performed with Affymetrix Gene Chips. The Gene Chip data were used for further calculations after the raw image and MAS5 analysis revealed a positive quality report. Ratios of average signal intensity (log 2) were calculated for the probe sets between pairs of cell lines and then converted to an average fold change (AFC). Statistical validation was performed on probe sets as described (Yoshida et al., 2004) . The statistical method used to assign P-values to the fold changes of gene responses is described by Yoshida et al. (2004) and is a two-step procedure based on the Benjamini and Yekutieli construction of false discovery rate confidence intervals (FDRCI) (Reiner et al., 2003) . Functional annotation of proteins was assigned through Gene Ontology (http://www. geneontology.org) or Locuslink (http://www.ncbi.nlm.nih.gov/ LocusLink) classifications obtained through appropriate public databases.
Quantitative RT-PCR RNA was reverse transcribed with SuperScript II (Invitrogen, Carlsabad, CA, USA) RT by priming with oligodT. The primers specific to validated genes were synthesized from the 3 0 untranslated region using Primer 3 software. PCR reactions were then performed in triplicates in an I-cycler Thermocycler with optical module (BioRad, Hercules, CA, USA). The amplified products were quantified by reading fluorescence of SybrGreen I (Molecular Probes, Eugene, OR, USA). Average fold changes were calculated by differences in threshold cycles (C t ) between pairs of samples to be compared. HPRT gene was used as a control.
Semiquantitative RT-PCR
The spectrophotometrically determined concentration of RNA was confirmed by amplifying actin message at different cycles. The cycling conditions that yielded proportional increment of amplified product was used to normalize the RNA concentration. The normalized RNA was used as template to determine relative abundance of transcripts corresponding to clones identified by RDA experiments. The conditions were standardized in the range of cycles that yielded a PCR product for at least one of the pairs of compared RNAs. Such experiments dictated cycles between 30 and 35 to be appropriate to compare abundance of selected transcripts in MCF7 and MDA-MB-231 cells.
Northern analysis
The expression pattern of selected transcripts in cell lines was also analysed in Northern blots. RNA (20 mm), as determined by spectrophotometer and confirmed by actin amplification, was electrophoresed on a formaldehyde agarose gel. A RNA ladder was used as a size marker. The RNAs were transferred from the gel to a Hybond nylon membrane by capillary transfer. The RNA was fixed onto the membrane by irradiation in a Stratalinker. The blot was hybridized at 651C for 12-15 h with a radioactive probe and the blot was subsequently washed with 0.1 Â SSC and 1% SDS at 651C. The hybridized probe was detected by autoradiography.
Transfection of MCF-7 cells with antisense constructs
The genes selected on the basis of their upregulation were cloned in antisense orientation in pCDNA3.1 vector (Invirogen). MCF-7 cells were grown to 70-80% confluence. Approximately 4 mg of DNA was transfected into MCF-7 cells by using Lipofectamine 2000. The transfected cells were grown in the presence of G418 (400 mg/ml). The transfectants were processed for protein isolation. A control set of cells was transfected with an empty pcDNA3.1. The proteins were analysed by two-dimensional electrophoresis, and altered bands were excised for mass spectrometry.
Protein isolation
The cultured cells were harvested by trypsinization and centrifuged at 220 g for 5 min at 41C. The cell pellet was washed once with ice-cold 1 Â PBS. The proteins were isolated by using a commercial kit (BioRad, Hercules, CA, USA). Briefly, pelleted cells (0.05 ml) were mixed with 0.5 ml ice-cold CPEB solution containing protease inhibitors cocktail (Roche), vortexed and stored on ice for 30 min. The cell suspension was passed through a syringe needle (20 gauge) for 10-20 strokes to ensure complete cell lysis. The cytoplasmic protein fraction was collected by centrifugation at 100 g for 10 min at 41C. The nuclear pellet was washed once again with 0.5 ml CPEB solution. The nuclear pellet was resuspended in 0.75 ml PSB buffer, vortexed briefly and centrifuged at 1000 g for 10 min at 41C, and the supernatant containing nuclear protein was collected into a new tube. The samples were quantified using 2D Quant kit (Amersham Biosciences), aliquoted and stored at À801C to prevent protein degradation. To reduce streaking, background staining and the other gel artefacts associated with substances contaminating 2D/IEF samples, the samples were cleaned with 2D Clean up kit (Bio Rad, Hercules, CA, USA) before running on the gel.
Two-dimensional gel electrophoresis
The protein mixtures were separated based on isoelectric points by using commercial pre-cast pH gradient gel strips according to the manufacturer's instructions. The protein sample (175 mg) in 185 ml of sample buffer (8 M urea, 2% CHAPS, 0.2% biolytes, 3/10 ampholytes, 65 mM DTT and 0.002% bromophenol blue) was loaded in the sample loading trays at the end of 11 cm immobilized rehydrated strips (pH 3-10) (Bio Rad, Hercules, CA, USA). Following isoelectric focusing, proteins were reduced and alkylated by successive 15 min treatments with equilibration buffer (6 M urea, 0.375 M Tris-HCl pH 8.8, 2% SDS, 20% glycerol, 2% DTT) and 2.5% (W/V) iodoacetamide, respectively. Proteins were then resolved in the second dimension on 8-16% gradient SDS-PAGE gel (Bio Rad, Hercules, CA, USA). The protein spots were visualized by staining with either silver stain or Coomassie blue stain. The gel images were compared and bands showing significant (greater than twofold) alterations in intensity were excised and processed for mass spectrometry. Comparisons were made between protein lysates from MCF-10A, MCF-7 and MDA-MB-231 cell lines or between MCF-7 and MCF-7 cells transfected with specific antisense constructs.
Protein identification by enzymatic digestion followed by mass spectrometry Prior to performing trypsin digestion, the gel pieces containing protein spots were washed sequentially once with water and twice with acetonitrile. The gel pieces were then allowed to swell in 100 mM ammonium bicarbonate and finally washed with acetonitrile. The washed slices were dried in a Speed Vac concentrator, and subsequently incubated with 20 ml of Promega's autocatalysis-resistant trypsin (12.5 ng/ml in 50 mM ammonium bicarbonate and 5 mM CaCl 2, pH 8.0) overnight at 371C. The supernatant (5 ml) from tryptic digest was injected for peptide sequence analysis using on-line capillary liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS). The front end HPLC utilized a Dionex (San Francisco, CA, USA) Vydac 300 mm inner diameter Â 15 mm C18 column. The linear acetonitrile gradient (3%/ min, containing 0.02% TFA) was developed using a HewlettPackard 1100 pump operating at 0.1 ml/min, and the flow was split before the injector such that the flow rate through the column was 3 ml/min. Peptides were detected at 215 nM. The inline mass spectrometer was a ThermoElectron LCQ-DECA instrument operated in data-dependent MS/MS mode, and proteins were identified by searching a nonredundant protein database using the Sequest program.
